FMC - Grand Island is a medicare approved dialysis facility center in Grand Island, Nebraska and it has 19 dialysis stations. It is located in Hall county at 3516 Richmond Circle, Grand Island, NE, 68803. You can reach out to the office of FMC - Grand Island at (308) 384-9600. This dialysis clinic is managed and/or owned by Fresenius Medical Care. FMC - Grand Island has the following ownership type - Profit. It was first certified by medicare in July, 2004. The medicare id for this facility is 282523 and it accepts patients under medicare ESRD program.
| Name | FMC - Grand Island |
|---|---|
| Location | 3516 Richmond Circle, Grand Island, Nebraska |
| No. of Dialysis Stations | 19 |
| Medicare ID | 282523 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 3516 Richmond Circle, Grand Island, Nebraska, 68803 | |
| (308) 384-9600 | |
News Archive
A new enzyme originally developed for commercial food processing turns out to also quickly and nearly-completely break down whole gluten molecules as well as the T cell stimulatory peptides that cause celiac disease, a digestive disease with no current effective treatment other than avoiding wheat, barley or rye products.
A patient's very own skin cells may hold the key to new treatments and even cures for devastating neurological diseases. A generous $1 million donation from Mr. J. Sebastian van Berkom, and critical partnerships with Brain Canada, Laval University, Marigold Foundation and the FRQS-Réseau Parkinson Quebec are driving an innovative, iPSC (induced pluripotent stem cell) research platform that will transform research into Parkinson's and other neurological diseases.
Humans face hundreds of decisions every day. But we're not alone. Even the tiniest viruses also make decisions, and scientists are researching how they do so, to help lead to better treatments for some diseases.
At an emergency meeting at the Rome headquarters of the U.N. Food and Agriculture Organization (FAO) on Monday, the agency announced "there will be a donors pledging conference Wednesday in Nairobi to raise as much as $1.6 billion to help fight famine in Somalia and other drought-stricken populations in East Africa," the Associated Press/Forbes reports.
› Verified 1 days ago
| NPI Number | 1922110824 |
| Organization Name | Kidney Dialysis Center Of Grand Island |
| Doing Business As | Rcg Grand Island, Llc |
| Address | 3516 Richmond Cir Grand Island, Nebraska, 68803 |
| Phone Number | (308) 384-9600 |
News Archive
A new enzyme originally developed for commercial food processing turns out to also quickly and nearly-completely break down whole gluten molecules as well as the T cell stimulatory peptides that cause celiac disease, a digestive disease with no current effective treatment other than avoiding wheat, barley or rye products.
A patient's very own skin cells may hold the key to new treatments and even cures for devastating neurological diseases. A generous $1 million donation from Mr. J. Sebastian van Berkom, and critical partnerships with Brain Canada, Laval University, Marigold Foundation and the FRQS-Réseau Parkinson Quebec are driving an innovative, iPSC (induced pluripotent stem cell) research platform that will transform research into Parkinson's and other neurological diseases.
Humans face hundreds of decisions every day. But we're not alone. Even the tiniest viruses also make decisions, and scientists are researching how they do so, to help lead to better treatments for some diseases.
At an emergency meeting at the Rome headquarters of the U.N. Food and Agriculture Organization (FAO) on Monday, the agency announced "there will be a donors pledging conference Wednesday in Nairobi to raise as much as $1.6 billion to help fight famine in Somalia and other drought-stricken populations in East Africa," the Associated Press/Forbes reports.
› Verified 1 days ago
| Dialysis patients with Hemoglobin data | 25 |
News Archive
A new enzyme originally developed for commercial food processing turns out to also quickly and nearly-completely break down whole gluten molecules as well as the T cell stimulatory peptides that cause celiac disease, a digestive disease with no current effective treatment other than avoiding wheat, barley or rye products.
A patient's very own skin cells may hold the key to new treatments and even cures for devastating neurological diseases. A generous $1 million donation from Mr. J. Sebastian van Berkom, and critical partnerships with Brain Canada, Laval University, Marigold Foundation and the FRQS-Réseau Parkinson Quebec are driving an innovative, iPSC (induced pluripotent stem cell) research platform that will transform research into Parkinson's and other neurological diseases.
Humans face hundreds of decisions every day. But we're not alone. Even the tiniest viruses also make decisions, and scientists are researching how they do so, to help lead to better treatments for some diseases.
At an emergency meeting at the Rome headquarters of the U.N. Food and Agriculture Organization (FAO) on Monday, the agency announced "there will be a donors pledging conference Wednesday in Nairobi to raise as much as $1.6 billion to help fight famine in Somalia and other drought-stricken populations in East Africa," the Associated Press/Forbes reports.
› Verified 1 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 47 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 417 |
| Percentage of adult patients getting regular hemodialysis at the center | 100 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
A new enzyme originally developed for commercial food processing turns out to also quickly and nearly-completely break down whole gluten molecules as well as the T cell stimulatory peptides that cause celiac disease, a digestive disease with no current effective treatment other than avoiding wheat, barley or rye products.
A patient's very own skin cells may hold the key to new treatments and even cures for devastating neurological diseases. A generous $1 million donation from Mr. J. Sebastian van Berkom, and critical partnerships with Brain Canada, Laval University, Marigold Foundation and the FRQS-Réseau Parkinson Quebec are driving an innovative, iPSC (induced pluripotent stem cell) research platform that will transform research into Parkinson's and other neurological diseases.
Humans face hundreds of decisions every day. But we're not alone. Even the tiniest viruses also make decisions, and scientists are researching how they do so, to help lead to better treatments for some diseases.
At an emergency meeting at the Rome headquarters of the U.N. Food and Agriculture Organization (FAO) on Monday, the agency announced "there will be a donors pledging conference Wednesday in Nairobi to raise as much as $1.6 billion to help fight famine in Somalia and other drought-stricken populations in East Africa," the Associated Press/Forbes reports.
› Verified 1 days ago
| Adult patients getting regular peritoneal dialysis at the center | 6 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 49 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
A new enzyme originally developed for commercial food processing turns out to also quickly and nearly-completely break down whole gluten molecules as well as the T cell stimulatory peptides that cause celiac disease, a digestive disease with no current effective treatment other than avoiding wheat, barley or rye products.
A patient's very own skin cells may hold the key to new treatments and even cures for devastating neurological diseases. A generous $1 million donation from Mr. J. Sebastian van Berkom, and critical partnerships with Brain Canada, Laval University, Marigold Foundation and the FRQS-Réseau Parkinson Quebec are driving an innovative, iPSC (induced pluripotent stem cell) research platform that will transform research into Parkinson's and other neurological diseases.
Humans face hundreds of decisions every day. But we're not alone. Even the tiniest viruses also make decisions, and scientists are researching how they do so, to help lead to better treatments for some diseases.
At an emergency meeting at the Rome headquarters of the U.N. Food and Agriculture Organization (FAO) on Monday, the agency announced "there will be a donors pledging conference Wednesday in Nairobi to raise as much as $1.6 billion to help fight famine in Somalia and other drought-stricken populations in East Africa," the Associated Press/Forbes reports.
› Verified 1 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at FMC - Grand Island with elevated calcium levels.
| Patients with hypercalcemia | 54 |
| Hypercalcemia patient months | 498 |
| Patients with Serumphosphor | 62 |
| Patients with Serumphosphor less than 3.5 mg/dL | 17 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 43 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 24 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 10 |
| Patients with Serumphosphor greater than 7 mg/dL | 6 |
News Archive
A new enzyme originally developed for commercial food processing turns out to also quickly and nearly-completely break down whole gluten molecules as well as the T cell stimulatory peptides that cause celiac disease, a digestive disease with no current effective treatment other than avoiding wheat, barley or rye products.
A patient's very own skin cells may hold the key to new treatments and even cures for devastating neurological diseases. A generous $1 million donation from Mr. J. Sebastian van Berkom, and critical partnerships with Brain Canada, Laval University, Marigold Foundation and the FRQS-Réseau Parkinson Quebec are driving an innovative, iPSC (induced pluripotent stem cell) research platform that will transform research into Parkinson's and other neurological diseases.
Humans face hundreds of decisions every day. But we're not alone. Even the tiniest viruses also make decisions, and scientists are researching how they do so, to help lead to better treatments for some diseases.
At an emergency meeting at the Rome headquarters of the U.N. Food and Agriculture Organization (FAO) on Monday, the agency announced "there will be a donors pledging conference Wednesday in Nairobi to raise as much as $1.6 billion to help fight famine in Somalia and other drought-stricken populations in East Africa," the Associated Press/Forbes reports.
› Verified 1 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 44 |
| Patient months included in arterial venous fistula and catheter summaries | 370 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 90 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 6 |
News Archive
A new enzyme originally developed for commercial food processing turns out to also quickly and nearly-completely break down whole gluten molecules as well as the T cell stimulatory peptides that cause celiac disease, a digestive disease with no current effective treatment other than avoiding wheat, barley or rye products.
A patient's very own skin cells may hold the key to new treatments and even cures for devastating neurological diseases. A generous $1 million donation from Mr. J. Sebastian van Berkom, and critical partnerships with Brain Canada, Laval University, Marigold Foundation and the FRQS-Réseau Parkinson Quebec are driving an innovative, iPSC (induced pluripotent stem cell) research platform that will transform research into Parkinson's and other neurological diseases.
Humans face hundreds of decisions every day. But we're not alone. Even the tiniest viruses also make decisions, and scientists are researching how they do so, to help lead to better treatments for some diseases.
At an emergency meeting at the Rome headquarters of the U.N. Food and Agriculture Organization (FAO) on Monday, the agency announced "there will be a donors pledging conference Wednesday in Nairobi to raise as much as $1.6 billion to help fight famine in Somalia and other drought-stricken populations in East Africa," the Associated Press/Forbes reports.
› Verified 1 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 52 |
| Hospitalization Rate in facility | 159.2 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 284.8 |
| Hospitalization Rate: Lower Confidence Limit | 92.7 |
News Archive
A new enzyme originally developed for commercial food processing turns out to also quickly and nearly-completely break down whole gluten molecules as well as the T cell stimulatory peptides that cause celiac disease, a digestive disease with no current effective treatment other than avoiding wheat, barley or rye products.
A patient's very own skin cells may hold the key to new treatments and even cures for devastating neurological diseases. A generous $1 million donation from Mr. J. Sebastian van Berkom, and critical partnerships with Brain Canada, Laval University, Marigold Foundation and the FRQS-Réseau Parkinson Quebec are driving an innovative, iPSC (induced pluripotent stem cell) research platform that will transform research into Parkinson's and other neurological diseases.
Humans face hundreds of decisions every day. But we're not alone. Even the tiniest viruses also make decisions, and scientists are researching how they do so, to help lead to better treatments for some diseases.
At an emergency meeting at the Rome headquarters of the U.N. Food and Agriculture Organization (FAO) on Monday, the agency announced "there will be a donors pledging conference Wednesday in Nairobi to raise as much as $1.6 billion to help fight famine in Somalia and other drought-stricken populations in East Africa," the Associated Press/Forbes reports.
› Verified 1 days ago
The rate of readmission show you whether patients who were being treated regularly at FMC - Grand Island were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 21.7 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 33 |
| Readmission Rate: Lower Confidence Limit | 12.6 |
News Archive
A new enzyme originally developed for commercial food processing turns out to also quickly and nearly-completely break down whole gluten molecules as well as the T cell stimulatory peptides that cause celiac disease, a digestive disease with no current effective treatment other than avoiding wheat, barley or rye products.
A patient's very own skin cells may hold the key to new treatments and even cures for devastating neurological diseases. A generous $1 million donation from Mr. J. Sebastian van Berkom, and critical partnerships with Brain Canada, Laval University, Marigold Foundation and the FRQS-Réseau Parkinson Quebec are driving an innovative, iPSC (induced pluripotent stem cell) research platform that will transform research into Parkinson's and other neurological diseases.
Humans face hundreds of decisions every day. But we're not alone. Even the tiniest viruses also make decisions, and scientists are researching how they do so, to help lead to better treatments for some diseases.
At an emergency meeting at the Rome headquarters of the U.N. Food and Agriculture Organization (FAO) on Monday, the agency announced "there will be a donors pledging conference Wednesday in Nairobi to raise as much as $1.6 billion to help fight famine in Somalia and other drought-stricken populations in East Africa," the Associated Press/Forbes reports.
› Verified 1 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at FMC - Grand Island get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .74 (As Expected) |
| SIR: Upper Confidence Limit | 2.44 |
| SIR: Lower Confidence Limit | .12 |
News Archive
A new enzyme originally developed for commercial food processing turns out to also quickly and nearly-completely break down whole gluten molecules as well as the T cell stimulatory peptides that cause celiac disease, a digestive disease with no current effective treatment other than avoiding wheat, barley or rye products.
A patient's very own skin cells may hold the key to new treatments and even cures for devastating neurological diseases. A generous $1 million donation from Mr. J. Sebastian van Berkom, and critical partnerships with Brain Canada, Laval University, Marigold Foundation and the FRQS-Réseau Parkinson Quebec are driving an innovative, iPSC (induced pluripotent stem cell) research platform that will transform research into Parkinson's and other neurological diseases.
Humans face hundreds of decisions every day. But we're not alone. Even the tiniest viruses also make decisions, and scientists are researching how they do so, to help lead to better treatments for some diseases.
At an emergency meeting at the Rome headquarters of the U.N. Food and Agriculture Organization (FAO) on Monday, the agency announced "there will be a donors pledging conference Wednesday in Nairobi to raise as much as $1.6 billion to help fight famine in Somalia and other drought-stricken populations in East Africa," the Associated Press/Forbes reports.
› Verified 1 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether FMC - Grand Island's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 45 |
| Transfusion Rate in facility | 19.8 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 83.9 |
| Transfusion Rate: Lower Confidence Limit | 5.6 |
News Archive
A new enzyme originally developed for commercial food processing turns out to also quickly and nearly-completely break down whole gluten molecules as well as the T cell stimulatory peptides that cause celiac disease, a digestive disease with no current effective treatment other than avoiding wheat, barley or rye products.
A patient's very own skin cells may hold the key to new treatments and even cures for devastating neurological diseases. A generous $1 million donation from Mr. J. Sebastian van Berkom, and critical partnerships with Brain Canada, Laval University, Marigold Foundation and the FRQS-Réseau Parkinson Quebec are driving an innovative, iPSC (induced pluripotent stem cell) research platform that will transform research into Parkinson's and other neurological diseases.
Humans face hundreds of decisions every day. But we're not alone. Even the tiniest viruses also make decisions, and scientists are researching how they do so, to help lead to better treatments for some diseases.
At an emergency meeting at the Rome headquarters of the U.N. Food and Agriculture Organization (FAO) on Monday, the agency announced "there will be a donors pledging conference Wednesday in Nairobi to raise as much as $1.6 billion to help fight famine in Somalia and other drought-stricken populations in East Africa," the Associated Press/Forbes reports.
› Verified 1 days ago
The rate of mortality show you whether patients who were being treated regularly at FMC - Grand Island lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 215 |
| Mortality Rate in facility | 14.1 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 20.3 |
| Mortality Rate: Lower Confidence Limit | 9.3 |
News Archive
A new enzyme originally developed for commercial food processing turns out to also quickly and nearly-completely break down whole gluten molecules as well as the T cell stimulatory peptides that cause celiac disease, a digestive disease with no current effective treatment other than avoiding wheat, barley or rye products.
A patient's very own skin cells may hold the key to new treatments and even cures for devastating neurological diseases. A generous $1 million donation from Mr. J. Sebastian van Berkom, and critical partnerships with Brain Canada, Laval University, Marigold Foundation and the FRQS-Réseau Parkinson Quebec are driving an innovative, iPSC (induced pluripotent stem cell) research platform that will transform research into Parkinson's and other neurological diseases.
Humans face hundreds of decisions every day. But we're not alone. Even the tiniest viruses also make decisions, and scientists are researching how they do so, to help lead to better treatments for some diseases.
At an emergency meeting at the Rome headquarters of the U.N. Food and Agriculture Organization (FAO) on Monday, the agency announced "there will be a donors pledging conference Wednesday in Nairobi to raise as much as $1.6 billion to help fight famine in Somalia and other drought-stricken populations in East Africa," the Associated Press/Forbes reports.
› Verified 1 days ago
Grand Island Dialysis Location: 203 East Stolley Park Road, Grand Island, Nebraska, 68801 Phone: (308) 384-4067 |
FMC - Grand Island Location: 3516 Richmond Circle, Grand Island, Nebraska, 68803 Phone: (308) 384-9600 |
News Archive
A new enzyme originally developed for commercial food processing turns out to also quickly and nearly-completely break down whole gluten molecules as well as the T cell stimulatory peptides that cause celiac disease, a digestive disease with no current effective treatment other than avoiding wheat, barley or rye products.
A patient's very own skin cells may hold the key to new treatments and even cures for devastating neurological diseases. A generous $1 million donation from Mr. J. Sebastian van Berkom, and critical partnerships with Brain Canada, Laval University, Marigold Foundation and the FRQS-Réseau Parkinson Quebec are driving an innovative, iPSC (induced pluripotent stem cell) research platform that will transform research into Parkinson's and other neurological diseases.
Humans face hundreds of decisions every day. But we're not alone. Even the tiniest viruses also make decisions, and scientists are researching how they do so, to help lead to better treatments for some diseases.
At an emergency meeting at the Rome headquarters of the U.N. Food and Agriculture Organization (FAO) on Monday, the agency announced "there will be a donors pledging conference Wednesday in Nairobi to raise as much as $1.6 billion to help fight famine in Somalia and other drought-stricken populations in East Africa," the Associated Press/Forbes reports.
› Verified 1 days ago